• Explore /
  • Poster
  • / Overall survival and long-term safety in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Updated analyses from INTRIGUE.

Overall survival and long-term safety in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Updated analyses from INTRIGUE.

Abstract Poster

Authors

Robin Jones

Robin Lewis Jones

Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom

Robin Lewis Jones , Jean-Yves Blay , Suzanne George , Hans Gelderblom , Patrick Schöffski , Margaret von Mehren , John Raymond Zalcberg , Yoon-Koo Kang , Albiruni Ryan Abdul Razak , Jonathan C. Trent , Axel Le Cesne , William Reichmann , Haroun Achour , Matthew L. Sherman , Rodrigo Ruiz-Soto , Sebastian Bauer , Michael C. Heinrich , Steven Attia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Gastrointestinal Stromal Tumors (GIST)

Clinical Trial Registration Number

NCT03673501

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11524)

DOI

10.1200/JCO.2023.41.16_suppl.11524

Abstract #

11524

Poster Bd #

458

Abstract Disclosures

Similar Posters

First Author: John Raymond Zalcberg

First Author: Jonathan C. Trent

First Author: Margaret von Mehren

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.

A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.

First Author: Takahito Awatsu